📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-08-13 21:05
453 analysed today
453
Today
133,342
All-time analysed
40,106
Positive
6,279
Negative
79,144
Neutral
7,745
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
9 announcements match the current filters (relevance ≥ 5).
Q1 Revenue up 68.7% YoY to ₹180 Cr; Auditor flags ₹66.8 Cr non-moving inventory
Halder Venture reported a strong 68.7% YoY revenue growth to ₹180.01 Cr for Q1 FY27, with net profit rising 42.7% to ₹5.61 Cr. However, the statutory auditor highlighted significant concerns regarding ₹66.83 Cr of inventory (rice and rice bran oil) that has been non-moving for over two years and is still carried at cost. Additionally, the company faces regulatory hurdles, including a contravention of the Companies Act regarding subsidiary shareholding and ongoing litigation over a ₹6.08 Cr Mumbai property. Finance costs remain elevated at ₹9.07 Cr, reflecting the company's high debt-to-equity ratio of 2.02.
Confidence: HIGH
What changedThe company has shown significant revenue scaling, likely from its Haldia refinery operations, but the Q1 filing reveals persistent auditor concerns regarding asset valuation and regulatory compliance.
Why it mattersWhile top-line growth is robust, the auditor's inability to verify the net realizable value of 10% of TTM revenue (inventory) poses a risk to future profitability if write-downs are required.
Revenue (Q1 FY27): ₹180.01 CrNet Profit (Q1 FY27): ₹5.61 CrNon-moving Inventory: ₹66.83 CrInventory vs Net Worth: ~37%Finance Cost (Q1 FY27): ₹9.07 CrWarrant Issue Price: ₹315
📅 Short termThe market may focus on the strong revenue growth, but the auditor's emphasis of matter regarding inventory and regulatory non-compliance could cap gains.
📈 Long termLong-term value depends on the successful integration of the Haldia refinery and the company's ability to deleverage its balance sheet (D/E 2.02) and resolve legacy asset issues.
⚠ Risk flags
- Non-moving inventory of ₹66.83 Cr (2+ years)
- Regulatory contravention of Section 19 (Subsidiary holding parent shares)
- High Debt-to-Equity ratio of 2.02
- Litigation on ₹6.08 Cr Mumbai property
Key Highlights
Revenue from operations grew 68.7% YoY to ₹180.01 Cr from ₹106.72 Cr.
Net profit increased 42.7% YoY to ₹5.61 Cr compared to ₹3.93 Cr in Q1 FY26.
Auditor flagged ₹66.83 Cr of inventory non-moving for over 2 years, representing ~37% of the company's net worth.
Finance costs rose to ₹9.07 Cr for the quarter, up from ₹8.22 Cr in the year-ago period.
Preferential allotment of 7,93,650 convertible warrants at ₹315 per warrant is currently ongoing.
👀 What to Watch
Investors should monitor the management's ability to liquidate the ₹66.83 Cr non-moving inventory without significant write-downs. Additionally, watch for the resolution of the subsidiary shareholding contravention and the technical evaluation of the Haldia plant assets which may increase future depreciation expenses.
Halder Venture Q1 FY27: Revenue up 69% to ₹180 Cr; Auditor flags ₹66.8 Cr non-moving inventory
Halder Venture reported a strong 68.7% YoY revenue growth to ₹180.01 Cr for Q1 FY27, with net profit rising 43% to ₹5.61 Cr. However, the statutory auditor issued an emphasis of matter regarding ₹66.83 Cr of rice and oil inventory that has been non-moving for over two years and is still carried at cost. The company is also in contravention of Section 19 of the Companies Act as its subsidiaries hold a 6.62% stake in the parent company. Furthermore, the transfer of leasehold rights for the ₹56.14 Cr Haldia refinery assets remains pending.
Confidence: HIGH
What changedThe company has significantly scaled its revenue run-rate, likely due to the integration of the Haldia refinery, but continues to carry legacy inventory and regulatory non-compliance issues.
Why it mattersThe high debt-to-equity ratio of 2.02 and the fact that non-moving inventory represents approximately 37% of the company's net worth pose significant financial risks despite the top-line growth.
Revenue (Q1 FY27): ₹180.01 CrNet Profit (Q1 FY27): ₹5.61 CrNon-moving Inventory: ₹66.83 CrInventory vs Net Worth: 37.3%Warrant Issue Price: ₹315.00
📅 Short termThe market may initially react to the strong revenue growth, but the auditor's concerns regarding inventory valuation and regulatory issues are likely to cause caution.
📈 Long termLong-term sustainability depends on the successful technical evaluation and depreciation of acquired assets and the company's ability to monetize old inventory without heavy losses.
⚠ Risk flags
- Inventory write-down risk (₹66.8 Cr non-moving)
- Regulatory non-compliance (Section 19)
- High Debt (D/E 2.02)
- Pending title transfer for Haldia and Mumbai assets
Key Highlights
Revenue from operations increased 68.7% YoY to ₹180.01 Cr from ₹106.72 Cr.
Net profit grew 42.8% YoY to ₹5.61 Cr compared to ₹3.93 Cr in the previous year's quarter.
Auditor flagged ₹38.98 Cr of rice and ₹27.85 Cr of rice bran oil inventory non-moving for over 24 months.
Subsidiaries hold 8,22,654 shares (6.62% stake) in contravention of Section 19 of the Companies Act.
Finance costs remained high at ₹9.07 Cr for the quarter, reflecting the company's ₹361 Cr debt load.
👀 What to Watch
Investors should monitor the disposal of the non-moving inventory, as any write-down to net realizable value could significantly impact the net worth of ₹179 Cr. Watch for the completion of the Haldia refinery lease transfer and the resolution of the subsidiary shareholding contravention.
Rs 1,000 Cr: Halder Venture seeks to triple borrowing limits and investment headroom
Halder Venture Ltd has issued a notice for its 44th AGM on September 07, 2026, proposing a massive increase in financial headroom. The company seeks shareholder approval to raise borrowing and investment/loan limits to Rs 1,000 Crores each, a significant jump from its current net worth of Rs 179 Crores. Other key items include the appointment of M/s P. Somani & Co. as statutory auditors for five years and a proposal to pay a 1% commission on net profits to Non-Executive Director Mrs. Poulomi Halder. This move signals potential large-scale expansion or M&A activity following its recent Haldia refinery acquisition.
Confidence: HIGH
What changedThe company is seeking shareholder approval to significantly expand its legal capacity to borrow and invest, moving from standard limits to a fixed cap of Rs 1,000 Crores.
Why it mattersThe proposed Rs 1,000 Cr limit is approximately 5.5x the company's current net worth and 2.6x its market cap, indicating a major shift in scale or potential for aggressive inorganic growth.
Proposed Borrowing Limit: Rs 1,000 CrLimit vs Current Net Worth: 558.6%Limit vs Market Cap: 263.8%Current Debt: Rs 361 CrCost Auditor Remuneration: Rs 1,00,000
📅 Short termNeutral in the immediate term as these are enabling resolutions; however, the market may react to the scale of ambition shown in the borrowing limits.
📈 Long termSignificant; the company is positioning itself for major capital deployment, likely linked to its strategy of operationalizing the Haldia refinery and expanding its 'Bhojmoti' brand.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- High leverage potential (current D/E is already 2.02)
- Related-party commission (1% of net profits to a Non-Executive Director)
- Execution risk on large-scale investments
Key Highlights
Proposed increase in borrowing limits under Section 180(1)(c) to Rs 1,000 Crores
Proposed increase in investment, loan, and guarantee limits under Section 186 to Rs 1,000 Crores
Proposed 1% commission on net profits for Non-Executive Director Mrs. Poulomi Halder starting FY 2026-27
Appointment of M/s P. Somani & Co. as Statutory Auditors for a 5-year term until the 49th AGM
AGM scheduled for September 07, 2026, to be held via Video Conferencing
👀 What to Watch
Investors should monitor the AGM voting results and look for management commentary regarding the specific utilization of the proposed Rs 1,000 Cr borrowing headroom, especially given the current high Debt-to-Equity ratio of 2.02.
Halder Venture proposes Rs 1,000 Cr borrowing limit at 44th AGM on Sept 7, 2026
Halder Venture has scheduled its 44th AGM for September 7, 2026, to seek shareholder approval for several key resolutions. The most significant proposal is to increase the company's borrowing and investment limits to Rs 1,000 crore each, which is approximately 5.6x its current net worth of Rs 179 crore. Other items include the appointment of M/s P. Somani & Co. as statutory auditors for five years and a new commission for a non-executive director capped at 1% of net profits. These enabling resolutions suggest the company is preparing for substantial capital deployment, likely for its Haldia refinery and export expansion.
Confidence: HIGH
What changedThe company is seeking to significantly expand its legal headroom for debt and investments, moving beyond its current capital structure constraints.
Why it mattersThe massive increase in borrowing limits (2.6x current market cap) provides the financial flexibility required to operationalize the newly acquired Haldia refinery and scale its 'Bhojmoti' brand, though it also signals potential for much higher leverage.
Proposed Borrowing Limit: Rs 1,000 CrLimit vs Net Worth: 558.6%Limit vs Market Cap: 263.8%Current Debt: Rs 361 CrDirector Commission Cap: 1% of net profitsCost Auditor Remuneration: Rs 1,00,000
📅 Short termNeutral. The market typically treats AGM notices as procedural; however, the high borrowing limit may lead to questions regarding the specific timeline for new debt and capex.
📈 Long termStructural. If the company utilizes these limits to successfully scale the Haldia refinery, it could significantly re-rate the revenue base, currently at Rs 646 Cr.
⚠ Risk flags
- Potential for high leverage (current D/E is already 2.02)
- Execution risk on large-scale investments
- Related-party remuneration through profit-linked commission
Key Highlights
Proposed borrowing limit increased to Rs 1,000 crore, significantly higher than the current debt of Rs 361 crore
Investment, loan, and guarantee limits also proposed to be capped at Rs 1,000 crore
Appointment of M/s P. Somani & Co. as Statutory Auditors for a 5-year term starting from this AGM
Proposal to pay commission to Non-Executive Director Mrs. Poulomi Halder up to 1% of annual net profits
AGM to be held virtually on September 7, 2026, to adopt FY26 audited financial statements
👀 What to Watch
Monitor the voting results of the AGM, particularly the special resolution for the Rs 1,000 crore borrowing limit, as this indicates the scale of management's future expansion ambitions.
Rs 25 Cr Fundraise: Halder Venture Allots 7.93 Lakh Warrants at Rs 315 per Share
Halder Venture Ltd has approved the allotment of 7,93,650 equity convertible warrants to P.K. Bio Link Private Limited, a non-promoter entity. The warrants are issued at Rs 315 per share, which is a significant premium of approximately 34% over the current market price of Rs 235.2. The total fundraise is valued at approximately Rs 25 crore, with the company having already received the mandatory 25% upfront subscription amount (approx. Rs 6.25 crore). This capital infusion is notable given the company's high debt-to-equity ratio of 2.02.
Confidence: HIGH
What changedThe company has successfully initiated a preferential fundraise from a non-promoter group at a price significantly higher than its current trading value.
Why it mattersThe fundraise provides a capital cushion of Rs 25 crore, which is meaningful relative to the company's net worth of Rs 179 crore, and the premium pricing suggests strong external valuation support.
Total Warrants Allotted: 7,93,650Issue Price per Warrant: Rs 315Total Fundraise Value: Rs 25 CrFundraise vs Market Cap: ~7.7%Premium over Market Price: ~34%Upfront Amount Received: 25%
📅 Short termThe announcement is likely to be viewed positively by the market due to the high issue price (Rs 315) compared to the current market price (Rs 235.2).
📈 Long termThe conversion of warrants will lead to equity dilution but provides necessary growth capital to scale the 'Bhojmoti' brand and Haldia refinery operations.
⚠ Risk flags
- Equity dilution upon warrant conversion
- High Debt-to-Equity ratio of 2.02
- Concentration of allotment to a single non-promoter entity
Key Highlights
Allotment of 7,93,650 equity convertible warrants to a single non-promoter allottee, P.K. Bio Link Private Limited.
Issue price set at Rs 315 per warrant, representing a ~34% premium to the current market price of Rs 235.2.
Total potential fundraise of Rs 25 crore, which is approximately 7.7% of the current market capitalization of Rs 326 crore.
Initial 25% of the subscription amount has been received by the company as per regulatory requirements.
Warrants are convertible into equivalent equity shares within 18 months from the date of allotment.
👀 What to Watch
Investors should monitor the specific utilization of these funds, particularly whether they are used to reduce the high debt of Rs 361 crore or to accelerate the operationalization of the Haldia refinery.
Rs 25 Cr Fundraise: Halder Venture Allots 7.93 Lakh Warrants at Rs 315 per Share
Halder Venture Ltd has approved the allotment of 7,93,650 equity convertible warrants to P.K. Bio Link Private Limited (Non-Promoter) at a price of Rs 315 per warrant. This represents a total fundraise of approximately Rs 25 crore, which is roughly 7.7% of the company's current market capitalization. The company has received the mandatory 25% upfront subscription amount (Rs 6.25 crore). The warrants are issued at a significant premium of ~34% over the current market price of Rs 235.2, indicating strong investor interest.
Confidence: HIGH
What changedThe company has successfully initiated a preferential fundraise from a non-promoter investor, securing immediate liquidity and a commitment for further capital.
Why it mattersThe fundraise at a 34% premium to the market price is a positive signal for a company with high debt (Rs 361 Cr). It provides necessary capital to support its expansion into edible oil refining and premium rice branding.
Total Warrants Allotted: 7,93,650Issue Price per Warrant: Rs 315Total Fundraise Value: Rs 25 CrFundraise vs Market Cap: ~7.7%Upfront Amount Received: Rs 6.25 Cr
📅 Short termThe announcement is likely to be viewed positively by the market due to the high issue price relative to the current market price.
📈 Long termIf the capital is effectively deployed to scale the Haldia refinery and reduce debt, it could improve the company's return profile and OPM (currently 4.2%).
⚠ Risk flags
- Equity dilution upon conversion of warrants
- High Debt-to-Equity ratio of 2.02
- Dependency on non-promoter to pay the remaining 75% for conversion
Key Highlights
Allotment of 7,93,650 equity convertible warrants to a non-promoter entity, P.K. Bio Link Private Limited.
Issue price fixed at Rs 315 per warrant, including a premium of Rs 305 per warrant.
Total fundraise value of approximately Rs 25 crore upon full conversion.
Initial 25% subscription amount (Rs 6.25 crore) already received by the company.
Warrants are convertible into equity shares within 18 months from the date of allotment.
👀 What to Watch
Investors should monitor the utilization of these funds, particularly whether they are used to deleverage the balance sheet (Debt/Equity is high at 2.02) or to accelerate the operationalization of the Haldia refinery.
CRISIL Upgrades Long-Term Rating to 'BBB-/Stable' for Rs 387.27 Cr Bank Facilities
Halder Venture Ltd has received a credit rating upgrade from CRISIL for its bank loan facilities totaling Rs 387.27 crore. The long-term rating has been moved to 'CRISIL BBB-/Stable' from 'CRISIL BB+/Stable ISSUER NOT COOPERATING', marking a shift to investment grade and the removal of the non-cooperation tag. The short-term rating was reassigned at 'CRISIL A3'. This rating action covers a wide range of facilities across multiple banks, including a significant Rs 115 crore cash credit from Bank of India.
Confidence: HIGH
What changedThe company's credit rating was upgraded to investment grade (BBB-) and the 'Issuer Not Cooperating' status was removed by CRISIL.
Why it mattersAn investment-grade rating improves the company's ability to negotiate better interest rates and access capital markets. The removal of the 'non-cooperating' tag significantly enhances corporate transparency and governance perception.
Total Rated Bank Facilities: Rs 387.27 CroreNew Long-Term Rating: CRISIL BBB-/StablePrevious Long-Term Rating: CRISIL BB+/Stable (INC)Short-Term Rating: CRISIL A3Largest Facility (Bank of India): Rs 115 Crore
📅 Short termThe upgrade is likely to be viewed positively by the market as it validates the company's improved financial discipline and cooperation with credit agencies.
📈 Long termThe shift to investment grade provides a structural advantage for future debt-funded expansions and reduces the risk premium associated with the company's debt.
⚠ Risk flags
- High concentration of debt in working capital (Cash Credit) facilities
- Rating validity is limited to March 31, 2027
Key Highlights
Total bank loan facilities rated at Rs 387.27 crore across 15 different bank lines
Long-term rating upgraded to CRISIL BBB-/Stable from CRISIL BB+/Stable (Issuer Not Cooperating)
Short-term rating reassigned at CRISIL A3 for non-fund based limits
Largest single facility is a Rs 115 crore Cash Credit from Bank of India
Rating validity is established until March 31, 2027
👀 What to Watch
Monitor the company's upcoming quarterly results to see if the improved credit profile translates into lower finance costs. Watch for any further updates on the utilization of the Rs 13.07 crore proposed term loan mentioned in the rating annexure.
Halder Venture receives approval for Rs 25 Cr+ fundraise via 7.93 lakh warrants
Halder Venture Ltd has received in-principle approval from both NSE and BSE for the issuance of up to 7,93,650 convertible warrants. These warrants are to be issued to non-promoters on a preferential basis at a minimum price of Rs. 315 per warrant. This represents a potential capital infusion of approximately Rs. 25 crore. The warrants are convertible into equity shares of Rs. 10 each on a 1:1 basis, subject to final allotment and listing procedures.
Confidence: HIGH
What changedThe company has secured the necessary exchange-level approvals to proceed with a preferential allotment of warrants to non-promoters.
Why it mattersThis fundraise provides the company with significant fresh capital (approx. Rs. 25 crore) to support its financial objectives while introducing new non-promoter stakeholders.
Total Warrants: 7,93,650Minimum Issue Price: Rs. 315Estimated Fundraise: Rs. 25 croreFace Value per Share: Rs. 10
📅 Short termThe receipt of regulatory approval is a positive milestone that clears the path for capital infusion, likely supporting stock sentiment in the near term.
📈 Long termThe long-term impact depends on the effective deployment of the Rs. 25 crore capital; successful execution could lead to business expansion or improved balance sheet strength.
⚠ Risk flags
- Equity dilution for existing shareholders upon warrant conversion
- Regulatory compliance risk regarding trading activity by allottees
Key Highlights
Issuance of up to 7,93,650 convertible warrants to non-promoter entities
Minimum issue price fixed at Rs. 315 per warrant, implying a total raise of at least Rs. 25 crore
In-principle approval received from both NSE and BSE on July 09, 2026
Warrants are convertible into equity shares of face value Rs. 10 each
Exchange has mandated strict internal controls to prevent insider trading by proposed allottees
👀 What to Watch
Investors should monitor the official allotment date and the subsequent disclosure regarding the specific utilization of these funds for business growth or debt reduction.
Rs 25 Cr Fundraise: Halder Venture Receives In-Principle Approval for 7.93 Lakh Warrants
Halder Venture Ltd has received in-principle approval from both NSE and BSE for the issuance of up to 7,93,650 convertible warrants. These warrants are to be issued to non-promoters on a preferential basis at a minimum price of Rs. 315 per unit. The total potential capital infusion is approximately Rs. 25 crore upon full conversion of these warrants into equity shares. This regulatory clearance allows the company to proceed with the allotment subject to standard SEBI (ICDR) compliance.
Confidence: HIGH
What changedThe company has secured the necessary preliminary regulatory approvals from stock exchanges to execute its planned preferential warrant issue.
Why it mattersA capital infusion of Rs. 25 crore provides the company with liquidity for potential expansion or debt reduction, though it will result in equity dilution for existing shareholders upon conversion.
Number of Warrants: 7,93,650Minimum Issue Price: Rs. 315Estimated Fundraise: Rs. 25 croreFace Value per Share: Rs. 10
📅 Short termThe stock may see positive sentiment in the short term as the regulatory hurdle for the fundraise has been cleared.
📈 Long termThe long-term impact depends on the effective deployment of the Rs. 25 crore capital and whether it generates returns exceeding the cost of equity dilution.
⚠ Risk flags
- Equity dilution for existing shareholders
- Risk of warrants not being converted if market price falls below Rs. 315
Key Highlights
In-principle approval received for 7,93,650 convertible warrants to non-promoters.
Minimum issue price fixed at Rs. 315 per warrant, representing a significant premium over the Rs. 10 face value.
Total estimated fundraise value stands at approximately Rs. 25 crore.
Approvals received from both NSE and BSE on July 09, 2026.
Warrants are convertible into an equal number of equity shares (1:1 ratio).
👀 What to Watch
Investors should monitor the official allotment date and the disclosure of the specific non-promoter entities participating in the fundraise to assess the quality of the new capital partners.
